Faculty Profile
David Veenstra, Pharm.D., Ph.D.
Dr. Veenstra is an Associate Professor in the Pharmaceutical Outcomes Research and Policy Program in the Department of Pharmacy, and a member of the Institute for Public Health Genetics at the University of Washington. He graduated from the University of California San Francisco, with doctoral degrees in clinical pharmacy and computational chemistry. He conducted his postdoctoral training in outcomes research with the University of Washington, including a one-year externship with Roche Global Pharmacoeconomics.
Dr. Veenstra’s primary research interests are the clinical, economic, and policy implications of pharmacogenomic-based drug therapies. His major research projects include association studies of genetic variants with the outcomes of warfarin treatment, and cost effectiveness studies of genetic tests for warfarin, breast cancer, and lung cancer therapies.
Dr. Veenstra’s other major research interest is the development of disease simulation models for chronic diseases, particularly hepatitis B. He has worked extensively with the Academy of Managed Care Pharmacy to develop guidelines and train decision makers in the practical application of cost-effectiveness models. Dr. Veenstra is an author on over 60 scientific publications, including the journals JAMA, NEJM, and Science.